1 - 25 of
85
results
for author:"Gibson J."
in Literature Citations
| Calbindin-1 association and Parkinson's disease. Soto-Ortolaza A.I., Behrouz B., Wider C., Vilarino-Guell C., Heckman M.G., Aasly J.O., Mark Gibson J., Lynch T., Jasinska-Myga B., Krygowska-Wajs A. et al. Eur. J. Neurol. 0:0-0(2009) · Mapped (5) |
| Phactr2 and Parkinson's disease. Wider C., Lincoln S.J., Heckman M.G., Diehl N.N., Stone J.T., Haugarvoll K., Aasly J.O., Gibson J.M., Lynch T., Rajput A. et al. Neurosci. Lett. 453:9-11(2009) · Mapped (11) |
| FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression. Wider C., Dachsel J.C., Soto A.I., Heckman M.G., Diehl N.N., Yue M., Lincoln S., Aasly J.O., Haugarvoll K., Trojanowski J.Q. et al. Mov. Disord. 24:455-459(2009) · Mapped (3) |
| Mutations in phospholipase C epsilon 1 are not sufficient to cause diffuse mesangial sclerosis. Gilbert R.D., Turner C.L., Gibson J., Bass P.S., Haq M.R., Cross E., Bunyan D.J., Collins A.R., Tapper W.J., Needell J.C. et al. Kidney Int. 75:415-419(2009) · Mapped (5) |
| Genetic variation of Omi/HtrA2 and Parkinson's disease. Ross O.A., Soto A.I., Vilarino-Guell C., Heckman M.G., Diehl N.N., Hulihan M.M., Aasly J.O., Sando S., Gibson J.M., Lynch T. et al. Parkinsonism Relat. Disord. 14:539-543(2008) · Mapped (2) |
| High resolution melting analysis of almond SNPs derived from ESTs. Wu S.B., Wirthensohn M.G., Hunt P., Gibson J.P., Sedgley M. Theor. Appl. Genet. 118:1-14(2008) · UniProtKB (14) |
| Dopamine beta-hydroxylase -1021C>T association and Parkinson's disease. Ross O.A., Heckman M.G., Soto A.I., Diehl N.N., Haugarvoll K., Vilarino-Guell C., Aasly J.O., Sando S., Gibson J.M., Lynch T. et al. Parkinsonism Relat. Disord. 14:544-547(2008) · Mapped (2) |
| Lack of association between LOXL1 variants and primary open-angle glaucoma in three different populations. Liu Y., Schmidt S., Qin X., Gibson J., Hutchins K., Santiago-Turla C., Wiggs J.L., Budenz D.L., Akafo S., Challa P. et al. Invest. Ophthalmol. Vis. Sci. 49:3465-3468(2008) · Mapped (2) |
| Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Haugarvoll K., Rademakers R., Kachergus J.M., Nuytemans K., Ross O.A., Gibson J.M., Tan E.K., Gaig C., Tolosa E., Goldwurm S. et al. Neurology 70:1456-1460(2008) · Mapped (4) |
| No association between OPA1 polymorphisms and primary open-angle glaucoma in three different populations. Liu Y., Schmidt S., Qin X., Gibson J., Munro D., Wiggs J.L., Hauser M.A., Allingham R.R. Mol. Vis. 13:2137-2141(2007) · Mapped (2) |
| Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors. Yu H., Gibson J.A., Pinkus G.S., Hornick J.L. Am. J. Clin. Pathol. 128:776-782(2007) · Mapped (2) |
| Dll3 and Notch1 genetic interactions model axial segmental and craniofacial malformations of human birth defects. Loomes K.M., Stevens S.A., O'Brien M.L., Gonzalez D.M., Ryan M.J., Segalov M., Dormans N.J., Mimoto M.S., Gibson J.D., Sewell W. et al. Dev. Dyn. 236:2943-2951(2007) · Mapped (15) |
| Interval timing in genetically modified mice: a simple paradigm. Balci F., Papachristos E.B., Gallistel C.R., Brunner D., Gibson J., Shumyatsky G.P. Genes Brain Behav. 7:373-384(2008) · Mapped (2) |
| Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Salonen J.T., Uimari P., Aalto J.M., Pirskanen M., Kaikkonen J., Todorova B., Hypponen J., Korhonen V.P., Asikainen J., Devine C. et al. Am. J. Hum. Genet. 81:338-345(2007) · Mapped (33) |
| Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Chubykin A.A., Atasoy D., Etherton M.R., Brose N., Kavalali E.T., Gibson J.R., Sudhof T.C. Neuron 54:919-931(2007) · Mapped (8) |
| Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease. Ross O.A., Gosal D., Stone J.T., Lincoln S.J., Heckman M.G., Irvine G.B., Johnston J.A., Gibson J.M., Farrer M.J., Lynch T. Mech. Ageing Dev. 128:378-382(2007) · Mapped (3) |
| An improved beta-lactamase reporter assay: multiplexing with a cytotoxicity readout for enhanced accuracy of hit identification. Hallis T.M., Kopp A.L., Gibson J., Lebakken C.S., Hancock M., Van Den Heuvel-Kramer K., Turek-Etienne T. J Biomol Screen 12:635-644(2007) · Mapped (1) |
| Systems genetic analysis of peripheral iron parameters in the mouse. Jones B.C., Beard J.L., Gibson J.N., Unger E.L., Allen R.P., McCarthy K.A., Earley C.J. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293:R116-24(2007) · Mapped (15) |
| Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Ross O.A., Haugarvoll K., Stone J.T., Heckman M.G., White L.R., Aasly J.O., Mark Gibson J., Lynch T., Wszolek Z.K., Uitti R.J. et al. Parkinsonism Relat. Disord. 13:386-388(2007) · Mapped (14) |
| Identification of oscillatory genes in somitogenesis from functional genomic analysis of a human mesenchymal stem cell model. William D.A., Saitta B., Gibson J.D., Traas J., Markov V., Gonzalez D.M., Sewell W., Anderson D.M., Pratt S.C., Rappaport E.F. et al. |
| ELAVL4, PARK10, and the Celts. Haugarvoll K., Toft M., Ross O.A., Stone J.T., Heckman M.G., White L.R., Lynch T., Gibson J.M., Wszolek Z.K., Uitti R.J. et al. Mov. Disord. 22:585-587(2007) · Mapped (6) |
| Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease. Toft M., Mata I.F., Ross O.A., Kachergus J., Hulihan M.M., Haugarvoll K., Stone J.T., Blazquez M., Gibson J.M., Aasly J.O. et al. Mov. Disord. 22:389-392(2007) · Mapped (4) |
| Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Heald A.H., Kaushal K., Siddals K.W., Rudenski A.S., Anderson S.G., Gibson J.M. Exp. Clin. Endocrinol. Diabetes 114:371-376(2006) · Mapped (17) |
| High resolution mapping of chromosomal regions controlling resistance to gastrointestinal nematode infections in an advanced intercross line of mice. Behnke J.M., Iraqi F.A., Mugambi J.M., Clifford S., Nagda S., Wakelin D., Kemp S.J., Baker R.L., Gibson J.P. Mamm. Genome 17:584-597(2006) · Mapped (26) |
| UCHL-1 is not a Parkinson's disease susceptibility gene. Healy D.G., Abou-Sleiman P.M., Casas J.P., Ahmadi K.R., Lynch T., Gandhi S., Muqit M.M., Foltynie T., Barker R., Bhatia K.P. et al. Ann. Neurol. 59:627-633(2006) · Mapped (4) |
